SCHEMBL3579472

SCHEMBL3579472

Cn1cc(C#N)c2c(-c3cccc(O)c3)cc[n+]([O-])c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.42
AR P10275 2/20 0.37
IKBKB O14920 1/20 0.34
CHUK O15111 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
CYP19A1 P11511 1/20 0.33
GLA P06280 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
PRKDC P78527 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
PLK4 O00444 1/20 0.32
ROCK2 O75116 1/20 0.32
RPS6KA5 O75582 1/20 0.32
MAP4K4 O95819 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13543862 0.78 LRRK2 (0.58) LRRK2ARIKBKBCHUKCYP19A1
Methane SCHEMBL3579468 0.77 LRRK2 (0.57) LRRK2ARIKBKBCHUKCYP19A1
SCHEMBL13798691 0.68 IKBKB (0.46) LRRK2ARIKBKBCHUKKDM4E
SCHEMBL1028218 0.65 ESR2 (0.65) LRRK2ARCYP19A1ADORA2AADORA1
SCHEMBL3579471 0.63 CHUK (0.47) LRRK2ARIKBKBCHUKKDM4E
SCHEMBL14509125 0.62 AR (0.48) LRRK2ARIKBKBCHUKKDM4E
SCHEMBL38660243 0.62 HSD17B1 (0.67) ALDH1A1
SCHEMBL3567725 0.59 LRRK2 (1.00) LRRK2IKBKBCHUKROCK2ROCK1
SCHEMBL7321021 0.59 KDM4E (0.72) LRRK2ARKDM4EALDH1A1GAA
SCHEMBL13885712 0.57 AR (0.65) ARCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100010037-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS VERNALIS (R&D) LTD. (GB) 2010-01-14 US disclosed
EP-2057155-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS Vernalis (R&D) Limited (GB) 2009-05-13 EP disclosed
WO-2008025947-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS VERNALIS (R & D) LTD. (GB) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100010037-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P LRRK2 2502/4885AR 353/4885IKBKB 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.